Delivery Order SPE2DX22D0010-SPE2D824FNS96
Award Date
6/28/24
Potential Completion Date
7/1/24
Potential Value
$6.4K
Federal Agency
Medical Supply Chain
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,567.13 to provide VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of November 27, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of VYVANSE 30 MG CAPSULE 100S to the Defense Logistics Agency (DLA). The contract, valued at $5,433.46, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, provides for the delivery of 4,564,491,226 units of the pharmaceutical product VYVANSE 20MG CAPSULE 100S to the Defense Logistics Agency (DLA). The firm-fixed-price contract, valued at $4,888.61, has a period of performance through May 6, 2024 and was awarded on May 3, 2024. Amerisourcebergen, a large pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The $2,003.28 firm fixed-price delivery order was awarded on May 21, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of May 22, 2024. The contract is not set aside for any specific business type. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,133.16 for the supply of VYVANSE 30 MG CAPSULE 100S. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, and has a period of performance through November 25, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,467.74 firm-fixed-price delivery order is for the supply of 4565532788 VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. This award is not associated with any set-aside program. The contract has an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds several indefinite...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,783.60. The contract is for the supply of VYVANSE 40 MG CAPSULE 100S, a pharmaceutical product, to the Defense Logistics Agency, a defense agency. The contract is not set aside and has a completion date of May 30, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of VYVANSE 30 MG CAPSULE 100S, a pharmaceutical product. The contract, valued at $5,556.49, was awarded by the Defense Logistics Agency (DLA), a defense agency, on June 5, 2024 and has a completion date of June 6, 2024. The contract is a delivery order with a firm fixed price pricing type and does not have a set-aside designation. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the provision of VYVANSE 70 MG CAPSULE 100S. The $1,929.46 firm fixed-price delivery order has an ultimate completion date of December 17, 2024 and was awarded on December 16, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,067.78 firm fixed-price delivery order is for the supply of VYVANSE 60 MG CAPSULE 100S to support federal healthcare programs. The contract has an ultimate completion date of October 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...